Via the Boston Globe: I was honored to serve last week as the emcee of the equity-themed 2019 North American Cannabis Summit in Los Angeles, an important gathering of non-industry marijuana stakeholders organized by Massachusetts-based Advocates for Human Potential. When I wasn’t reminding people where to find their bagged lunches,Read More →
From Berkeley News: UC Berkeley’s new Cannabis Research Center, announced today by a multidisciplinary team of faculty, will explore how cannabis production impacts the environment and society, and how these impacts will evolve under new regulations set in place by legalization. While other research groups in the University of CaliforniaRead More →
The use of a cannabis spray as part of the treatment plan for certain patients with cancer is taking another step forward with the announcement of continued clinical research by the New South Wales-based Medlab Clinical LTD. The phase I study is being led by Professor Stephen Clarke and hasRead More →
Add United States Surgeon General Doctor Jerome Adams to the list of experts advocating for the reclassification of cannabis as a Schedule 1 drug in order to ease up U.S. researchers access to the materials needed to conduct studies. The Surgeon General is one of many who believes that theRead More →
Anheuser-Busch, the makers of Budweiser, and British Columbia-based Tilray have embarked on a research partnership to the tune of $50M to research both CBD and THC for the burgeoning cannabis-infused beverage market. The announcement comes after several other prominent beer-makers have made their own moves towards the canna-beverages space. BackRead More →
Dr. Brooke J. Arterberry (Iowa State University in Ames) and colleagues have determined that onset of cannabis-use disorder (CUD) after first-use may be precipitated by the strength of the cannabis at the time of first use and further study is needed. The likelihood of progressing from cannabis initiation to aRead More →
Here’s what’s happening today in the world of CBD research, products and announcements: It’s Time To Remove Cannabis From The Federal Drug Schedules “One reason there has been so little in the United States is precisely because cannabis is listed on Schedule I, a designation that creates significant barriers toRead More →
Dr. M-J Milloy holds the inaugural post of Canopy Growth Professor of Cannabis Science at the University of British Columbia. He says there’s still so much research needed to confirm our beliefs about the effects of cannabis on human subjects. Dr. Milloy is interested to see if cannabis offers treatmentRead More →
![Evaluating the Therapeutic Potential of Cannabinoids: How to conduct research within the current regulatory framework [VIDEO]](https://www.crforum.io/wp-content/uploads/2018/12/fda-690x500.jpg)
On December 8, 2018, the following NIH-sponsored proceeding took place: “Evaluating the Therapeutic Potential of Cannabinoids: How to conduct research within the current regulatory framework“ From the website: The National Center for Complementary and Integrative Health (NCCIH), at the National Institutes of Health (NIH), sponsored a workshop on December 8,Read More →
Canada continues to lead the way in terms of applied cannabis research. The Ontario Long Term Care Association is embarking on a study of 500 seniors in the Ontario region to study the effects of cannabis use among seniors in long-term care. The outcomes of the study will inform policyRead More →